We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+14.33%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.3B
AUM Growth
+$2.76B
(+7.3%)
Cap. Flow
-$1.55B
Cap. Flow
% of AUM
-3.85%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
2,266
New
182
Increased
649
Reduced
1,111
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GoDaddy
GDDY
|
+$83M |
| 2 |
Morgan Stanley
MS
|
+$67.7M |
| 3 |
Structure Therapeutics
GPCR
|
+$66.3M |
| 4 |
AbbVie
ABBV
|
+$63.8M |
| 5 |
Kenvue
KVUE
|
+$60.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$207M |
| 2 |
Williams Companies
WMB
|
+$150M |
| 3 |
Verizon
VZ
|
+$128M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$123M |
| 5 |
Cisco
CSCO
|
+$93.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.22% |
| 2 | Technology | 16.21% |
| 3 | Financials | 12.58% |
| 4 | Industrials | 9.78% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Ultragenyx Pharmaceutical
RARE
$2.5B
| $117M | 0.29% |
2,446,500
+250,000
| +11% | +$9.69M |
|
77
Zoetis
ZTS
$32.9B
| $116M | 0.29% |
587,785
-43,105
| -7% | -$7.63M |
|
78
Ameriprise Financial
AMP
$48.2B
| $116M | 0.29% |
304,953
+17,307
| +6% | +$5.93M |
|
79
Xylem
XYL
$28.4B
| $114M | 0.28% |
993,974
-109,711
| -10% | -$10.9M |
|
|
80
Morgan Stanley
MS
$323B
| $113M | 0.28% |
1,215,753
+846,266
| +229% | +$67.7M |
|
81
American Tower
AMT
$81.7B
| $113M | 0.28% |
522,330
+33,477
| +7% | +$6.33M |
|
82
Capital One
COF
$130B
| $112M | 0.28% |
855,509
-6,616
| -0.8% | -$714K |
|
83
JPMorgan Chase
JPM
$931B
| $112M | 0.28% |
656,836
+57,774
| +10% | +$8.76M |
|
84
Salesforce
CRM
$152B
| $110M | 0.27% |
418,196
+6,525
| +2% | +$1.48M |
|
85
TJX Companies
TJX
$179B
| $110M | 0.27% |
1,169,906
-103,842
| -8% | -$9.32M |
|
86
Sherwin-Williams
SHW
$83.8B
| $109M | 0.27% |
349,257
+47,008
| +16% | +$12.6M |
|
87
lululemon athletica
LULU
$13.5B
| $107M | 0.27% |
210,201
-32,029
| -13% | -$13.8M |
|
88
Palo Alto Networks
PANW
$257B
| $107M | 0.27% |
726,266
+150,366
| +26% | +$20.1M |
|
89
Rhythm Pharmaceuticals
RYTM
$7.32B
| $106M | 0.26% |
2,310,955
-30,380
| -1% | -$958K |
|
|
FUSN
90
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $105M | 0.26% |
10,886,153
+202,364
| +2% | +$983K |
|
91
S&P Global
SPGI
$123B
| $104M | 0.26% |
236,089
-20,436
| -8% | -$8.06M |
|
92
Blue Owl Capital
OWL
$6.51B
| $104M | 0.26% |
6,973,500
| – | – |
|
93
Legend Biotech
LEGN
$3.64B
| $104M | 0.26% |
1,725,972
-38,524
| -2% | -$2.44M |
|
94
NNN REIT
NNN
$9.39B
| $104M | 0.26% |
2,409,544
-12,205
| -0.5% | -$473K |
|
95
Veeva Systems
VEEV
$33.7B
| $102M | 0.25% |
530,328
+17,668
| +3% | +$3.33M |
|
|
96
GoDaddy
GDDY
$13.6B
| $101M | 0.25% |
955,559
+928,273
| +3,402% | +$83M |
|
97
HEICO Corp
HEI
$49.4B
| $101M | 0.25% |
567,103
+45,993
| +9% | +$7.79M |
|
98
Merck
MRK
$322B
| $101M | 0.25% |
928,318
-10,639
| -1% | -$1.1M |
|
|
MRUS
99
DELISTED
Merus
MRUS
| $100M | 0.25% |
3,637,309
+751,609
| +26% | +$17.6M |
|
100
Blackrock
BLK
$170B
| $99.8M | 0.25% |
122,985
-5,393
| -4% | -$3.76M |
|
Similar funds
Federated Hermes's Q4 2023 Portfolio in Review
As of Q4 2023, Federated Hermes held 2,266 positions worth $40.3B, up 7.3% from $37.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Federated Hermes withdrew a net $1.55B in Q4 2023, closing 232 positions and reducing 1,111 holdings. Its most notable exit was Splunk Inc, an estimated $123M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
Against the trend, Federated Hermes opened a new position in Zscaler worth $39.2M.
- Federated Hermes's largest Q4 2023 buy was Zscaler: 177,136 shares worth $39.2M.
- Federated Hermes added most to GoDaddy in Q4 2023, an estimated $83M increase.
- Federated Hermes's biggest Q4 2023 reduction was Amgen, cutting an estimated $207M.
- Federated Hermes fully exited Splunk Inc in Q4 2023, selling an estimated $123M.
- Federated Hermes's ten largest holdings make up 14% of its $40.3B portfolio in Q4 2023.
- Federated Hermes opened 182 new positions and closed 232 in Q4 2023.
- Federated Hermes's portfolio value rose 7.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q4 2023, filed 31 Jan 2024.